Experimental ID,Genome Assembly,Antigen Class,Antigen,Cell Type Class,Cell Type,Cell Type Description,Title,Meta Data,Processing Logs,BigWig,Peak-call (BED) (q < 1E-05),Peak-call (BED) (q < 1E-10),Peak-call (BED) (q < 1E-20),Peak-call (BigBed) (q < 1E-05),Peak-call (BigBed) (q < 1E-10),Peak-call (BigBed) (q < 1E-20)
DRX135461,hg19,TFs and others,TP53,Lung,NCI-H1299,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma Non-Small Cell,Illumina Genome Analyzer IIx sequencing of SAMD00131353,sample_name=ChIP-seq (H1299 LacZ p53 IP) || cell_line=H1299,"33740362,15.5,56.4,3791",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/DRX135461.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/DRX135461.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/DRX135461.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/DRX135461.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/DRX135461.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/DRX135461.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/DRX135461.20.bb
DRX135462,hg19,TFs and others,TP53,Lung,NCI-H1299,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma Non-Small Cell,Illumina Genome Analyzer IIx sequencing of SAMD00131354,sample_name=ChIP-seq (H1299 p53 IP) || cell_line=H1299,"29608136,23.7,34.3,4478",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/DRX135462.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/DRX135462.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/DRX135462.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/DRX135462.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/DRX135462.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/DRX135462.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/DRX135462.20.bb
ERX159257,hg19,TFs and others,TP53,Digestive tract,LoVo,Primary Tissue=Colon|Tissue Diagnosis=Adenocarcinoma,,"Alias=LoVo_TP53 || Description=Chromatin immunoprecipitation of TP53 transcription factor from LoVo cells. Antibody used in the assay was from Santa Cruz, (sc-135773 X) || INSDC center alias=KI-BN || INSDC center name=Department of Biosciences and Nutrition, Karolinska Institutet, Sweden || INSDC first public=2013-01-18T09:17:04Z || INSDC last update=2012-10-24T16:35:18Z || INSDC status=public || SRA accession=ERS183069 || Sample Name=ERS183069 || Title=LoVo_TP53","13908769,25.2,8.5,185",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX159257.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX159257.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX159257.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX159257.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX159257.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX159257.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX159257.20.bb
ERX159258,hg19,TFs and others,TP53,Digestive tract,LoVo,Primary Tissue=Colon|Tissue Diagnosis=Adenocarcinoma,,"Alias=LoVo_TP53 || Description=Chromatin immunoprecipitation of TP53 transcription factor from LoVo cells. Antibody used in the assay was from Santa Cruz, (sc-135773 X) || INSDC center alias=KI-BN || INSDC center name=Department of Biosciences and Nutrition, Karolinska Institutet, Sweden || INSDC first public=2013-01-18T09:17:04Z || INSDC last update=2012-10-24T16:35:18Z || INSDC status=public || SRA accession=ERS183069 || Sample Name=ERS183069 || Title=LoVo_TP53","6673120,22.2,3.7,69",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX159258.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX159258.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX159258.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX159258.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX159258.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX159258.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX159258.20.bb
ERX159259,hg19,TFs and others,TP53,Digestive tract,LoVo,Primary Tissue=Colon|Tissue Diagnosis=Adenocarcinoma,,"Alias=LoVo_TP53 || Description=Chromatin immunoprecipitation of TP53 transcription factor from LoVo cells. Antibody used in the assay was from Santa Cruz, (sc-135773 X) || INSDC center alias=KI-BN || INSDC center name=Department of Biosciences and Nutrition, Karolinska Institutet, Sweden || INSDC first public=2013-01-18T09:17:04Z || INSDC last update=2012-10-24T16:35:18Z || INSDC status=public || SRA accession=ERS183069 || Sample Name=ERS183069 || Title=LoVo_TP53","6496355,21.0,3.5,60",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX159259.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX159259.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX159259.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX159259.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX159259.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX159259.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX159259.20.bb
ERX181465,hg19,TFs and others,TP53,Bone,Saos-2,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,Characterization of the p53 cistrome - DNA binding cooperativity dissects p53's tumor suppressor functions,"Alias=E-MTAB-1394:SAOS+p53wt || Broker name=ArrayExpress || Description=Protocols: SAOS cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 10 % fetal bovine serum (PAA) and penicillin/streptomycin (Life Technologies) using standard conditions and procedures. Cells were transduced with recombinant adenovirus containing p53 wildtype, p53 R181E mutant, p53 E180R mutant, p53 R181E_E180R double mutant or GFP as previously described (Cam et al., 2006). ChIP was perfomed with a p53-specific antibody. The DNA was purified with the Qiaquick PCR purification Kit (Qiagen). || INSDC center alias=University of Marburg || INSDC center name=University of Marburg || INSDC first public=2014-02-14T17:02:00Z || INSDC last update=2018-03-08T16:10:48Z || INSDC status=public || SRA accession=ERS197247 || Sample Name=ERS197247 || Title=SAOS+p53wt || cell line=SAOS || immunoprecipitate=Anti-p53, sc-126, Santa-cruz || transfection=p53wt","202394853,10.3,83.6,13908",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX181465.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX181465.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX181465.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX181465.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX181465.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX181465.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX181465.20.bb
ERX181466,hg19,TFs and others,TP53,Bone,Saos-2,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,Characterization of the p53 cistrome - DNA binding cooperativity dissects p53's tumor suppressor functions,"Alias=E-MTAB-1394:SAOS+GFP || Broker name=ArrayExpress || Description=Protocols: SAOS cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 10 % fetal bovine serum (PAA) and penicillin/streptomycin (Life Technologies) using standard conditions and procedures. Cells were transduced with recombinant adenovirus containing p53 wildtype, p53 R181E mutant, p53 E180R mutant, p53 R181E_E180R double mutant or GFP as previously described (Cam et al., 2006). ChIP was perfomed with a p53-specific antibody. The DNA was purified with the Qiaquick PCR purification Kit (Qiagen). || INSDC center alias=University of Marburg || INSDC center name=University of Marburg || INSDC first public=2014-02-14T17:02:00Z || INSDC last update=2018-03-08T16:10:48Z || INSDC status=public || SRA accession=ERS197248 || Sample Name=ERS197248 || Title=SAOS+GFP || cell line=SAOS || immunoprecipitate=Anti-p53, sc-126, Santa-cruz || transfection=mock","206677850,7.7,69.8,2309",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX181466.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX181466.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX181466.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX181466.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX181466.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX181466.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX181466.20.bb
ERX181467,hg19,TFs and others,TP53,Bone,Saos-2,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,Characterization of the p53 cistrome - DNA binding cooperativity dissects p53's tumor suppressor functions,"Alias=E-MTAB-1394:SAOS+p53EE/RR || Broker name=ArrayExpress || Description=Protocols: SAOS cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 10 % fetal bovine serum (PAA) and penicillin/streptomycin (Life Technologies) using standard conditions and procedures. Cells were transduced with recombinant adenovirus containing p53 wildtype, p53 R181E mutant, p53 E180R mutant, p53 R181E_E180R double mutant or GFP as previously described (Cam et al., 2006). ChIP was perfomed with a p53-specific antibody. The DNA was purified with the Qiaquick PCR purification Kit (Qiagen). || INSDC center alias=University of Marburg || INSDC center name=University of Marburg || INSDC first public=2014-02-14T17:02:00Z || INSDC last update=2018-03-08T16:10:48Z || INSDC status=public || SRA accession=ERS197249 || Sample Name=ERS197249 || Title=SAOS+p53EE/RR || cell line=SAOS || immunoprecipitate=Anti-p53, sc-126, Santa-cruz || transfection=EE/RR","209977470,12.9,81.7,35289",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX181467.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX181467.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX181467.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX181467.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX181467.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX181467.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX181467.20.bb
ERX181468,hg19,TFs and others,TP53,Bone,Saos-2,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,Characterization of the p53 cistrome - DNA binding cooperativity dissects p53's tumor suppressor functions,"Alias=E-MTAB-1394:SAOS+p53RR || Broker name=ArrayExpress || Description=Protocols: SAOS cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 10 % fetal bovine serum (PAA) and penicillin/streptomycin (Life Technologies) using standard conditions and procedures. Cells were transduced with recombinant adenovirus containing p53 wildtype, p53 R181E mutant, p53 E180R mutant, p53 R181E_E180R double mutant or GFP as previously described (Cam et al., 2006). ChIP was perfomed with a p53-specific antibody. The DNA was purified with the Qiaquick PCR purification Kit (Qiagen). || INSDC center alias=University of Marburg || INSDC center name=University of Marburg || INSDC first public=2014-02-14T17:02:00Z || INSDC last update=2018-03-08T16:10:48Z || INSDC status=public || SRA accession=ERS197250 || Sample Name=ERS197250 || Title=SAOS+p53RR || cell line=SAOS || immunoprecipitate=Anti-p53, sc-126, Santa-cruz || transfection=RR","192735554,13.1,78.9,5932",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX181468.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX181468.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX181468.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX181468.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX181468.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX181468.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX181468.20.bb
ERX181469,hg19,TFs and others,TP53,Bone,Saos-2,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,Characterization of the p53 cistrome - DNA binding cooperativity dissects p53's tumor suppressor functions,"Alias=E-MTAB-1394:SAOS+p53EE || Broker name=ArrayExpress || Description=Protocols: SAOS cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 10 % fetal bovine serum (PAA) and penicillin/streptomycin (Life Technologies) using standard conditions and procedures. Cells were transduced with recombinant adenovirus containing p53 wildtype, p53 R181E mutant, p53 E180R mutant, p53 R181E_E180R double mutant or GFP as previously described (Cam et al., 2006). ChIP was perfomed with a p53-specific antibody. The DNA was purified with the Qiaquick PCR purification Kit (Qiagen). || INSDC center alias=University of Marburg || INSDC center name=University of Marburg || INSDC first public=2014-02-14T17:02:00Z || INSDC last update=2018-03-08T16:10:48Z || INSDC status=public || SRA accession=ERS197251 || Sample Name=ERS197251 || Title=SAOS+p53EE || cell line=SAOS || immunoprecipitate=Anti-p53, sc-126, Santa-cruz || transfection=EE","213903005,12.9,73.3,4803",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX181469.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX181469.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX181469.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX181469.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX181469.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX181469.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX181469.20.bb
ERX1974188,hg19,TFs and others,TP53,Lung,NCI-H1299,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma Non-Small Cell,Illumina HiSeq 2500 sequencing; ChIP-seq of H1299 cells stably transfected with empty vector or the p53 mutant R273H,Alias=E-MTAB-5653:R273H p53-1 || Broker name=ArrayExpress || Description=Protocols: ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG || ENA checklist=ERC000011 || INSDC center alias=VCU || INSDC center name=Virginia Commonwealth University || INSDC first public=2017-04-16T17:01:30Z || INSDC last update=2017-04-06T15:43:01Z || INSDC status=public || SRA accession=ERS1649041 || Sample Name=ERS1649041 || Title=R273H p53-1 || cell_line=NCI-H1299 || genotype=p53-R273H || organism=Homo sapiens,"15499229,86.2,4.0,22091",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX1974188.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX1974188.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX1974188.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX1974188.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX1974188.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX1974188.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX1974188.20.bb
ERX1974189,hg19,TFs and others,TP53,Lung,NCI-H1299,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma Non-Small Cell,Illumina HiSeq 2500 sequencing; ChIP-seq of H1299 cells stably transfected with empty vector or the p53 mutant R273H,Alias=E-MTAB-5653:R273H p53-2 || Broker name=ArrayExpress || Description=Protocols: ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG || ENA checklist=ERC000011 || INSDC center alias=VCU || INSDC center name=Virginia Commonwealth University || INSDC first public=2017-04-16T17:01:30Z || INSDC last update=2017-04-06T15:43:01Z || INSDC status=public || SRA accession=ERS1649042 || Sample Name=ERS1649042 || Title=R273H p53-2 || cell_line=NCI-H1299 || genotype=p53-R273H || organism=Homo sapiens,"15334144,86.0,4.0,22084",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX1974189.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX1974189.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX1974189.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX1974189.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX1974189.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX1974189.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX1974189.20.bb
ERX1974192,hg19,TFs and others,TP53,Lung,NCI-H1299,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma Non-Small Cell,Illumina HiSeq 2500 sequencing; ChIP-seq of H1299 cells stably transfected with empty vector or the p53 mutant R273H,Alias=E-MTAB-5653:Vector p53-1 || Broker name=ArrayExpress || Description=Protocols: ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG || ENA checklist=ERC000011 || INSDC center alias=VCU || INSDC center name=Virginia Commonwealth University || INSDC first public=2017-04-16T17:01:30Z || INSDC last update=2017-04-06T15:43:01Z || INSDC status=public || SRA accession=ERS1649045 || Sample Name=ERS1649045 || Title=Vector p53-1 || cell_line=NCI-H1299 || genotype=pcmv Bam || organism=Homo sapiens,"16560317,55.2,8.3,1392",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX1974192.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX1974192.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX1974192.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX1974192.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX1974192.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX1974192.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX1974192.20.bb
ERX1974193,hg19,TFs and others,TP53,Lung,NCI-H1299,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma Non-Small Cell,Illumina HiSeq 2500 sequencing; ChIP-seq of H1299 cells stably transfected with empty vector or the p53 mutant R273H,Alias=E-MTAB-5653:Vector p53-2 || Broker name=ArrayExpress || Description=Protocols: ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG ChIP-seq of H1299 cells stably transfected with empty vector (Vector) or the p53 mutant R273H and ChIP'd for p53 or IgG || ENA checklist=ERC000011 || INSDC center alias=VCU || INSDC center name=Virginia Commonwealth University || INSDC first public=2017-04-16T17:01:30Z || INSDC last update=2017-04-06T15:43:01Z || INSDC status=public || SRA accession=ERS1649046 || Sample Name=ERS1649046 || Title=Vector p53-2 || cell_line=NCI-H1299 || genotype=pcmv Bam || organism=Homo sapiens,"16656462,54.9,8.4,1454",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX1974193.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX1974193.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX1974193.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX1974193.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX1974193.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX1974193.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX1974193.20.bb
ERX2734532,hg19,TFs and others,TP53BP1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",Illumina HiSeq 2500 sequencing; ChIP-Seq mapping of histone modifications at multiple DNA Double Strand Breaks,"Alias=E-MTAB-58171533046345:53BP1_AS_pOHT || Broker name=ArrayExpress || Description=Protocols: DIvA (AsiSI-ER-U20S) cells were cultured in Dulbeccofs modified Eaglefs medium (DMEM) supplemented with antibiotics, 10% FCS (InVitrogenInvitrogen) with 1 g/mL puromycin (DIvA cells) at 37C under a humidified atmosphere with 5% CO2. For AsiSI-dependent DSB induction, cells were treated with 300 nM 4OHT (Sigma; H7904) for 4h For ChIP:Formaldehyde was added to the culture medium at a final concentration of 1% and crosslinking was allowed to proceed for 15 min at room temperature. Reaction was stopped by adding glycine (0.125M final concentration) and incubation for 5 minutes at room temperature. Cells were washed twice with PBS and harvested by scraping. Cell lysis was performed by incubation in cell lysis buffer (5 mM Pipes pH 8, 85 mM KCl, 0.5% IGEPAL CA-630) followed by Dounce homogenization. Nuclei were harvested by centrifugation and incubated in nuclear lysis buffer: (50 mM Tris pH 8.1, 10 mM EDTA, 1% SDS) and sonicated 10 times for 10 s at a power setting of 5 and 50% duty cycle (Branson Sonifier 250). Samples were diluted 10 times in ChIP dilution buffer (16.7 mM Tris pH 8.1, 167 mM NaCl, 1.2 mM EDTA, 1.1% Triton X]100, 0.01% SDS) and precleared using a mixture of protein A-agarose (Pierce) and protein G-sepharose (Sigma) previously blocked with BSA (Sigma). Precleared samples (10 to 200 Êg) were incubated overnight at 4C with indicated antibodies. Immune complexes were recovered by incubation with blocked protein A/protein G beads for 2 h at 4C on a rotating wheel. Beads were washed once in dialysis buffer (50 mM Tris pH 8, 2 mM EDTA, 0.2% Sarkosyl), five times in wash buffer (100 mM Tris pH 8.8, 500 mM LiCl, 1% IGEPAL CA-630, 1% NaDoc) and twice with TE (10mM Tris-HCl, pH 8, 1mM EDTA). Beads were resuspended in TE supplemented with 50g/ml DNase-free RNase A (Abcam) and incubated for 30 minutes at 37C. SDS (final concentration 0.5%) was added and crosslink was reversed by overnight incubation at 70C. Following a 2 hours treatment with 200 g/ml proteinase K (Roche) at 45C, DNA was purified by phenol/chloroform extraction and recovered by ethanol precipitation in presence of 5 g glycogen (Invitrogen). DNA pellet was resuspended in water. Prior to next-generation sequencing library preparation, samples from multiples ChIP experiments were pooled and sonicated for 5 cycles (30 seconds on, 30 seconds off, high setting) on a Bioruptor (Diagenode) then concentrated with a vacuum concentrator (Eppendorf). Libraries for H3K4me2, H4K20me1, H3K36me3, H3K79me2, H2Bub, H3K56ac, H4K16ac, H3K9me2, H4S1P, H3K36me2 and ÁH2AX were prepared BGI (Beijin Genomics Institute, Hong Kong) using proprietary protocols. Libraries for FK2 samples were prepared at GATC biotech (Konstanz, Germany) using proprietary protocols. Libraries for H2BK120ac, H2AZ, H1, MacroH2A, H4K20me3, 53BP1, H4K12ac, H2AZac and H3 were prepared atEMBL Genomics core facilities (Heidelberg, Germany) using NEBNext ChIP-Seq Library Prep kit (New England Biolabs). Libraries for BLESS were prepared using TruSeq Nano DNA LT Library Preparation Kit (Illumina). || ENA checklist=ERC000011 || INSDC center alias=Universite de Toulouse ; UPS ; LBCMCP ; 118 route de Narbonne, 31062, Toulouse, France;CNRS ; LBCMCP ; F-31062 Toulouse, France || INSDC center name=Universite de Toulouse ; UPS ; LBCMCP ; 118 route de Narbonne, 31062, Toulouse, France;CNRS ; LBCMCP ; F-31062 Toulouse, France || INSDC first public=2018-09-28T13:00:54Z || INSDC last update=2018-07-31T15:21:41Z || INSDC status=public || SRA accession=ERS2630358 || Sample Name=ERS2630358 || Title=53BP1_AS_pOHT || cell_line=U2OS || genotype=AsiSI-ER expression || organism=Homo sapiens || sex=female","129041155,69.8,26.7,1379",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX2734532.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX2734532.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX2734532.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX2734532.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX2734532.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX2734532.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX2734532.20.bb
ERX2734533,hg19,TFs and others,TP53BP1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",Illumina HiSeq 2500 sequencing; ChIP-Seq mapping of histone modifications at multiple DNA Double Strand Breaks,"Alias=E-MTAB-58171533046345:53BP1_G1_pOHT || Broker name=ArrayExpress || Description=Protocols: DIvA (AsiSI-ER-U20S) cells were cultured in Dulbeccofs modified Eaglefs medium (DMEM) supplemented with antibiotics, 10% FCS (InVitrogenInvitrogen) with 1 g/mL puromycin (DIvA cells) at 37C under a humidified atmosphere with 5% CO2. For AsiSI-dependent DSB induction, cells were treated with 300 nM 4OHT (Sigma; H7904) for 4h For ChIP:Formaldehyde was added to the culture medium at a final concentration of 1% and crosslinking was allowed to proceed for 15 min at room temperature. Reaction was stopped by adding glycine (0.125M final concentration) and incubation for 5 minutes at room temperature. Cells were washed twice with PBS and harvested by scraping. Cell lysis was performed by incubation in cell lysis buffer (5 mM Pipes pH 8, 85 mM KCl, 0.5% IGEPAL CA-630) followed by Dounce homogenization. Nuclei were harvested by centrifugation and incubated in nuclear lysis buffer: (50 mM Tris pH 8.1, 10 mM EDTA, 1% SDS) and sonicated 10 times for 10 s at a power setting of 5 and 50% duty cycle (Branson Sonifier 250). Samples were diluted 10 times in ChIP dilution buffer (16.7 mM Tris pH 8.1, 167 mM NaCl, 1.2 mM EDTA, 1.1% Triton X]100, 0.01% SDS) and precleared using a mixture of protein A-agarose (Pierce) and protein G-sepharose (Sigma) previously blocked with BSA (Sigma). Precleared samples (10 to 200 Êg) were incubated overnight at 4C with indicated antibodies. Immune complexes were recovered by incubation with blocked protein A/protein G beads for 2 h at 4C on a rotating wheel. Beads were washed once in dialysis buffer (50 mM Tris pH 8, 2 mM EDTA, 0.2% Sarkosyl), five times in wash buffer (100 mM Tris pH 8.8, 500 mM LiCl, 1% IGEPAL CA-630, 1% NaDoc) and twice with TE (10mM Tris-HCl, pH 8, 1mM EDTA). Beads were resuspended in TE supplemented with 50g/ml DNase-free RNase A (Abcam) and incubated for 30 minutes at 37C. SDS (final concentration 0.5%) was added and crosslink was reversed by overnight incubation at 70C. Following a 2 hours treatment with 200 g/ml proteinase K (Roche) at 45C, DNA was purified by phenol/chloroform extraction and recovered by ethanol precipitation in presence of 5 g glycogen (Invitrogen). DNA pellet was resuspended in water. Prior to next-generation sequencing library preparation, samples from multiples ChIP experiments were pooled and sonicated for 5 cycles (30 seconds on, 30 seconds off, high setting) on a Bioruptor (Diagenode) then concentrated with a vacuum concentrator (Eppendorf). Libraries for H3K4me2, H4K20me1, H3K36me3, H3K79me2, H2Bub, H3K56ac, H4K16ac, H3K9me2, H4S1P, H3K36me2 and ÁH2AX were prepared BGI (Beijin Genomics Institute, Hong Kong) using proprietary protocols. Libraries for FK2 samples were prepared at GATC biotech (Konstanz, Germany) using proprietary protocols. Libraries for H2BK120ac, H2AZ, H1, MacroH2A, H4K20me3, 53BP1, H4K12ac, H2AZac and H3 were prepared atEMBL Genomics core facilities (Heidelberg, Germany) using NEBNext ChIP-Seq Library Prep kit (New England Biolabs). Libraries for BLESS were prepared using TruSeq Nano DNA LT Library Preparation Kit (Illumina). || ENA checklist=ERC000011 || INSDC center alias=Universite de Toulouse ; UPS ; LBCMCP ; 118 route de Narbonne, 31062, Toulouse, France;CNRS ; LBCMCP ; F-31062 Toulouse, France || INSDC center name=Universite de Toulouse ; UPS ; LBCMCP ; 118 route de Narbonne, 31062, Toulouse, France;CNRS ; LBCMCP ; F-31062 Toulouse, France || INSDC first public=2018-09-28T13:00:54Z || INSDC last update=2018-07-31T15:21:41Z || INSDC status=public || SRA accession=ERS2630359 || Sample Name=ERS2630359 || Title=53BP1_G1_pOHT || cell_line=U2OS || genotype=AsiSI-ER expression || organism=Homo sapiens || sex=female","80741308,25.2,70.7,2872",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX2734533.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX2734533.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX2734533.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX2734533.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX2734533.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX2734533.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX2734533.20.bb
ERX2734534,hg19,TFs and others,TP53BP1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",Illumina HiSeq 2500 sequencing; ChIP-Seq mapping of histone modifications at multiple DNA Double Strand Breaks,"Alias=E-MTAB-58171533046345:53BP1_G2_pOHT || Broker name=ArrayExpress || Description=Protocols: DIvA (AsiSI-ER-U20S) cells were cultured in Dulbeccofs modified Eaglefs medium (DMEM) supplemented with antibiotics, 10% FCS (InVitrogenInvitrogen) with 1 g/mL puromycin (DIvA cells) at 37C under a humidified atmosphere with 5% CO2. For AsiSI-dependent DSB induction, cells were treated with 300 nM 4OHT (Sigma; H7904) for 4h For ChIP:Formaldehyde was added to the culture medium at a final concentration of 1% and crosslinking was allowed to proceed for 15 min at room temperature. Reaction was stopped by adding glycine (0.125M final concentration) and incubation for 5 minutes at room temperature. Cells were washed twice with PBS and harvested by scraping. Cell lysis was performed by incubation in cell lysis buffer (5 mM Pipes pH 8, 85 mM KCl, 0.5% IGEPAL CA-630) followed by Dounce homogenization. Nuclei were harvested by centrifugation and incubated in nuclear lysis buffer: (50 mM Tris pH 8.1, 10 mM EDTA, 1% SDS) and sonicated 10 times for 10 s at a power setting of 5 and 50% duty cycle (Branson Sonifier 250). Samples were diluted 10 times in ChIP dilution buffer (16.7 mM Tris pH 8.1, 167 mM NaCl, 1.2 mM EDTA, 1.1% Triton X]100, 0.01% SDS) and precleared using a mixture of protein A-agarose (Pierce) and protein G-sepharose (Sigma) previously blocked with BSA (Sigma). Precleared samples (10 to 200 Êg) were incubated overnight at 4C with indicated antibodies. Immune complexes were recovered by incubation with blocked protein A/protein G beads for 2 h at 4C on a rotating wheel. Beads were washed once in dialysis buffer (50 mM Tris pH 8, 2 mM EDTA, 0.2% Sarkosyl), five times in wash buffer (100 mM Tris pH 8.8, 500 mM LiCl, 1% IGEPAL CA-630, 1% NaDoc) and twice with TE (10mM Tris-HCl, pH 8, 1mM EDTA). Beads were resuspended in TE supplemented with 50g/ml DNase-free RNase A (Abcam) and incubated for 30 minutes at 37C. SDS (final concentration 0.5%) was added and crosslink was reversed by overnight incubation at 70C. Following a 2 hours treatment with 200 g/ml proteinase K (Roche) at 45C, DNA was purified by phenol/chloroform extraction and recovered by ethanol precipitation in presence of 5 g glycogen (Invitrogen). DNA pellet was resuspended in water. Prior to next-generation sequencing library preparation, samples from multiples ChIP experiments were pooled and sonicated for 5 cycles (30 seconds on, 30 seconds off, high setting) on a Bioruptor (Diagenode) then concentrated with a vacuum concentrator (Eppendorf). Libraries for H3K4me2, H4K20me1, H3K36me3, H3K79me2, H2Bub, H3K56ac, H4K16ac, H3K9me2, H4S1P, H3K36me2 and ÁH2AX were prepared BGI (Beijin Genomics Institute, Hong Kong) using proprietary protocols. Libraries for FK2 samples were prepared at GATC biotech (Konstanz, Germany) using proprietary protocols. Libraries for H2BK120ac, H2AZ, H1, MacroH2A, H4K20me3, 53BP1, H4K12ac, H2AZac and H3 were prepared atEMBL Genomics core facilities (Heidelberg, Germany) using NEBNext ChIP-Seq Library Prep kit (New England Biolabs). Libraries for BLESS were prepared using TruSeq Nano DNA LT Library Preparation Kit (Illumina). || ENA checklist=ERC000011 || INSDC center alias=Universite de Toulouse ; UPS ; LBCMCP ; 118 route de Narbonne, 31062, Toulouse, France;CNRS ; LBCMCP ; F-31062 Toulouse, France || INSDC center name=Universite de Toulouse ; UPS ; LBCMCP ; 118 route de Narbonne, 31062, Toulouse, France;CNRS ; LBCMCP ; F-31062 Toulouse, France || INSDC first public=2018-09-28T13:00:54Z || INSDC last update=2018-07-31T15:21:41Z || INSDC status=public || SRA accession=ERS2630360 || Sample Name=ERS2630360 || Title=53BP1_G2_pOHT || cell_line=U2OS || genotype=AsiSI-ER expression || organism=Homo sapiens || sex=female","83869882,28.4,66.6,2942",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/ERX2734534.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/ERX2734534.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/ERX2734534.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/ERX2734534.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/ERX2734534.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/ERX2734534.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/ERX2734534.20.bb
SRX016979,hg19,TFs and others,TP53,Bone,Saos-2,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,GSM501691: p53 ChIPSeq replicate1,source_name=p53 Saos-2 cell line || cell line=Saos-2 || cell type=osteosarcoma || antibody=DO1 against p53 || genetic modification=Tet-on FLp53,"10376398,56.4,5.7,3116",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX016979.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX016979.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX016979.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX016979.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX016979.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX016979.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX016979.20.bb
SRX016980,hg19,TFs and others,TP53,Bone,Saos-2,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,GSM501692: p53 ChIPSeq replicate2,source_name=p53 Saos-2 cell line || cell line=Saos-2 || cell type=osteosarcoma || antibody=DO1 against p53 || genetic modification=Tet-on FLp53,"19904164,91.3,6.1,18550",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX016980.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX016980.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX016980.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX016980.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX016980.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX016980.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX016980.20.bb
SRX017559,hg19,TFs and others,TP53,Epidermis,BJ,Primary Tissue=Skin|Tissue Diagnosis=Normal,GSM508793: BJ +RAS IPp53,"source_name=BJ primary foreskin fibroblasts, wildtype p53 IP || cell line=BJ || cell type=foreskin fibroblasts || oncogene expression=RasV12 || vector=empty || antibody=anti-p53 || sample type=experiment","10540925,61.0,9.0,1549",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX017559.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX017559.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX017559.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX017559.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX017559.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX017559.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX017559.20.bb
SRX017560,hg19,TFs and others,TP53,Epidermis,BJ,Primary Tissue=Skin|Tissue Diagnosis=Normal,GSM508794: BJ p53KD +RAS IPp53,"source_name=BJ primary foreskin fibroblasts, p53 knockdown IP || cell line=BJ || cell type=foreskin fibroblasts || oncogene expression=RasV12 || vector=p53 knockdown || antibody=anti-p53 || sample type=control","10468397,62.9,11.7,1639",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX017560.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX017560.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX017560.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX017560.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX017560.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX017560.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX017560.20.bb
SRX020764,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM545807: p53 ActD ChIPSeq,source_name=Chromatin IP against p53 || cell line=U2OS || cell type=osteosarcoma || antibody=DO1 (BD PharMingen) || compound=Actinomycin D || dose=5 nM,"8325066,79.1,6.6,1524",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX020764.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX020764.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX020764.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX020764.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX020764.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX020764.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX020764.20.bb
SRX020765,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM545808: p53 Eto ChIPSeq,source_name=Chromatin IP against p53 || cell line=U2OS || cell type=osteosarcoma || antibody=DO1 (BD PharMingen) || compound=Etoposide || dose=10 ÊM,"8399535,81.9,5.3,2248",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX020765.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX020765.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX020765.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX020765.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX020765.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX020765.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX020765.20.bb
SRX020766,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM545809: p53-pS15 ActD ChIPSeq,source_name=Chromatin IP against p53-pS15 || cell line=U2OS || cell type=osteosarcoma || antibody=¿-p53-pS15 (Cell Signaling) || compound=Actinomycin D || dose=5 nM,"11993970,67.7,4.1,2052",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX020766.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX020766.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX020766.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX020766.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX020766.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX020766.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX020766.20.bb
SRX020767,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM545810: p53-pS15 Eto ChIPSeq,source_name=Chromatin IP against p53-pS15 || cell line=U2OS || cell type=osteosarcoma || antibody=¿-p53-pS15 (Cell Signaling) || compound=Etoposide || dose=10 ÊM,"12208380,69.5,3.7,1807",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX020767.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX020767.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX020767.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX020767.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX020767.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX020767.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX020767.20.bb
SRX020768,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM545811: p53-pS46 ActD ChIPSeq,source_name=Chromatin IP against p53-pS46 || cell line=U2OS || cell type=osteosarcoma || antibody=¿-p53-pS15 (Cell Signaling) || compound=Actinomycin D || dose=5 nM,"7420650,75.1,4.2,218",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX020768.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX020768.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX020768.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX020768.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX020768.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX020768.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX020768.20.bb
SRX020769,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM545812: p53-pS46 Eto ChIPSeq,source_name=Chromatin IP against p53-pS46 || cell line=U2OS || cell type=osteosarcoma || antibody=¿-p53-pS15 (Cell Signaling) || compound=Etoposide || dose=10 ÊM,"9042067,83.3,5.9,601",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX020769.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX020769.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX020769.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX020769.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX020769.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX020769.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX020769.20.bb
SRX093319,hg19,TFs and others,TP53,Lung,IMR-90,Primary Tissue=Lung|Tissue Diagnosis=Normal,GSM783262: p53 ChIP-seq,source_name=normal human lung fibroblasts || cell line=IMR90 || pdl=38-40 || chip antibody=p53-specific DO1 || antibody vendor=Santa Kruz Biotechnology Inc. || catalog number=sc126X [200mg/0.1ml],"7473100,62.8,26.2,378",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX093319.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX093319.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX093319.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX093319.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX093319.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX093319.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX093319.20.bb
SRX131373,hg19,TFs and others,TP53,Epidermis,MDAH087,,GSM900168: MDAH087 p53 ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=MDAH087 fibroblast cell line || cell type=Fibroblast cells from Li Fraumeni patient || mutant p53=R248W || antibody=p53 (FL-393; Santa Cruz; sc-6243),"34950595,62.2,4.1,1272",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX131373.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX131373.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX131373.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX131373.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX131373.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX131373.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX131373.20.bb
SRX1384027,hg19,TFs and others,TP53,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,GSM1917772: p53-CPT; Homo sapiens; ChIP-Seq,"source_name=HCT116 colon cancer cells, p53-WT, camptothecin, p53 ChIP || cell line=HCT116 || cell type=colon cancer cell line || genotype/variation=p53-WT || treatment=camptothecin || chip antibody=p53","14330799,21.0,9.0,7521",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX1384027.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX1384027.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX1384027.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX1384027.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX1384027.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX1384027.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX1384027.20.bb
SRX1384028,hg19,TFs and others,TP53,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,GSM1917773: p53-KO; Homo sapiens; ChIP-Seq,"source_name=HCT116 colon cancer cells, p53-KO, p53 ChIP || cell line=HCT116 || cell type=colon cancer cell line || genotype/variation=p53-KO || treatment=DMSO || chip antibody=p53","11973781,15.6,10.9,7058",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX1384028.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX1384028.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX1384028.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX1384028.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX1384028.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX1384028.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX1384028.20.bb
SRX1547996,hg19,TFs and others,TP53,Epidermis,Dermal fibroblast,,GSM2046276: EM2; Homo sapiens; ChIP-Seq,"source_name=foreskin HDF, DMSO, IP || cell line=foreskin HDF || passage=p4 || chip antibody=p53-DO1 (Santa Cruz, catalog# sc126, lot#K2613) || treatment=DMSO","53984227,38.4,55.1,3295",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX1547996.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX1547996.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX1547996.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX1547996.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX1547996.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX1547996.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX1547996.20.bb
SRX1547998,hg19,TFs and others,TP53,Epidermis,Dermal fibroblast,,GSM2046278: EM4; Homo sapiens; ChIP-Seq,"source_name=foreskin HDF, Nutlin, IP || cell line=foreskin HDF || passage=p4 || chip antibody=p53-DO1 (Santa Cruz, catalog# sc126, lot#K2613) || treatment=Nutlin-3a 10 ÊM","52699131,25.6,70.5,4714",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX1547998.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX1547998.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX1547998.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX1547998.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX1547998.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX1547998.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX1547998.20.bb
SRX1728403,hg19,TFs and others,TP53,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,mcf10a EVp53,isolate=not available || age=36 || biomaterial_provider=ATCC || sex=female || tissue=nontumorigenic mammary epithelial || cell_line=MCF10A || sample_type=IP DNA || treatment=No treatment || Antibody=Anti-p53 DO-1,"27482537,45.4,52.2,760",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX1728403.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX1728403.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX1728403.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX1728403.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX1728403.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX1728403.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX1728403.20.bb
SRX189249,hg19,TFs and others,TP53,Pluripotent stem cell,hESC H9,,GSM981235: Untreated p53 ChIPSeq; Homo sapiens; ChIP-Seq,source_name=H9 hESC || cell type=Pluripotent hESC || chip antibody=p53 || antibody vendor=Santa Cruz Biotechnology,"15012584,16.0,83.8,203",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX189249.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX189249.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX189249.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX189249.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX189249.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX189249.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX189249.20.bb
SRX189250,hg19,TFs and others,TP53,Pluripotent stem cell,hESC H9,,GSM981236: Damaged p53 ChIPSeq; Homo sapiens; ChIP-Seq,source_name=H9 hESC || cell type=DOX-damaged induced hESC || chip antibody=p53 || antibody vendor=Santa Cruz Biotechnology,"16785262,76.9,15.5,3795",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX189250.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX189250.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX189250.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX189250.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX189250.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX189250.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX189250.20.bb
SRX189251,hg19,TFs and others,TP53,Pluripotent stem cell,hESC H9,,GSM981237: Differentiating p53 ChIPSeq; Homo sapiens; ChIP-Seq,source_name=H9 hESC || cell type=RA-mediated differentiating hESC || chip antibody=p53 || antibody vendor=Santa Cruz Biotechnology,"14655106,48.9,50.8,1277",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX189251.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX189251.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX189251.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX189251.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX189251.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX189251.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX189251.20.bb
SRX2060918,hg19,TFs and others,TP53,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"GSM2296271: HCT116, ChIP-Seq, DMSO treated; Homo sapiens; ChIP-Seq","source_name=HCT116, DMSO treated || cell line=Colorectal Adenocarcinoma Cell Line HCT116 || chip antibody=p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181) || treatment=DMSO","59402402,92.6,4.4,1623",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX2060918.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX2060918.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX2060918.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX2060918.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX2060918.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX2060918.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX2060918.20.bb
SRX2060919,hg19,TFs and others,TP53,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"GSM2296272: HCT116, ChIP-Seq, Nutlin treated; Homo sapiens; ChIP-Seq","source_name=HCT116, Nutlin treated || cell line=Colorectal Adenocarcinoma Cell Line HCT116 || chip antibody=p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181) || treatment=Nutlin","52502156,91.5,4.9,7014",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX2060919.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX2060919.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX2060919.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX2060919.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX2060919.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX2060919.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX2060919.20.bb
SRX2060921,hg19,TFs and others,TP53,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"GSM2296274: MCF7, ChIP-Seq, DMSO treated; Homo sapiens; ChIP-Seq","source_name=MCF7, DMSO treated || cell line=Breast Carcinoma Cell Line MCF7 || chip antibody=p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181) || treatment=DMSO","63678086,92.4,5.2,1670",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX2060921.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX2060921.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX2060921.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX2060921.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX2060921.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX2060921.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX2060921.20.bb
SRX2060922,hg19,TFs and others,TP53,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"GSM2296275: MCF7, ChIP-Seq, Nutlin treated; Homo sapiens; ChIP-Seq","source_name=MCF7, Nutlin treated || cell line=Breast Carcinoma Cell Line MCF7 || chip antibody=p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181) || treatment=Nutlin","67102600,86.0,9.4,30333",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX2060922.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX2060922.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX2060922.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX2060922.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX2060922.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX2060922.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX2060922.20.bb
SRX2060924,hg19,TFs and others,TP53,Bone,SJSA-1,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,"GSM2296277: SJSA, ChIP-Seq, DMSO treated; Homo sapiens; ChIP-Seq","source_name=SJSA, DMSO treated || cell line=Osteosarcoma Cell Line SJSA || chip antibody=p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181) || treatment=DMSO","48946329,82.7,10.5,3056",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX2060924.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX2060924.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX2060924.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX2060924.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX2060924.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX2060924.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX2060924.20.bb
SRX2060925,hg19,TFs and others,TP53,Bone,SJSA-1,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,"GSM2296278: SJSA, ChIP-Seq, Nutlin treated; Homo sapiens; ChIP-Seq","source_name=SJSA, Nutlin treated || cell line=Osteosarcoma Cell Line SJSA || chip antibody=p53 (DO1) (Calbiochem, catalog# OP43-100mg, lot# 2635181) || treatment=Nutlin","60020748,87.9,8.2,13202",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX2060925.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX2060925.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX2060925.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX2060925.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX2060925.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX2060925.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX2060925.20.bb
SRX208484,hg19,TFs and others,TP53,Lung,IMR-90,Primary Tissue=Lung|Tissue Diagnosis=Normal,GSM1048850: Growing p53; Homo sapiens; ChIP-Seq,"source_name=IMR90 Human Fetal Lung Fibroblast cell line || chip antibody=p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909] || cell line=IMR90 || cell type=Human Fetal Lung Fibroblast cell line","16193281,9.0,68.6,2859",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX208484.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX208484.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX208484.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX208484.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX208484.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX208484.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX208484.20.bb
SRX208485,hg19,TFs and others,TP53,Lung,IMR-90,Primary Tissue=Lung|Tissue Diagnosis=Normal,GSM1048851: Senescent/shLuc p53; Homo sapiens; ChIP-Seq,"source_name=IMR90 Human Fetal Lung Fibroblast cell line || chip antibody=p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909] || cell line=IMR90 || cell type=Human Fetal Lung Fibroblast cell line","15758864,12.7,59.2,5757",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX208485.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX208485.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX208485.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX208485.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX208485.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX208485.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX208485.20.bb
SRX208486,hg19,TFs and others,TP53,Lung,IMR-90,Primary Tissue=Lung|Tissue Diagnosis=Normal,GSM1048852: Senescent/shp53 p53; Homo sapiens; ChIP-Seq,"source_name=IMR90 Human Fetal Lung Fibroblast cell line || chip antibody=p53 antibody (Cat number: sc-126 DO-1) from Santa Cruz (10 ug) [mouse monoclonal antibody, Lot:F0909] || cell line=IMR90 || cell type=Human Fetal Lung Fibroblast cell line","15099856,15.5,48.9,4346",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX208486.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX208486.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX208486.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX208486.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX208486.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX208486.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX208486.20.bb
SRX2585782,hg19,TFs and others,TP53,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma",GSM2501568: LM2 TP53 ChIPSeq; Homo sapiens; ChIP-Seq,source_name=p53 ChIP-Seq in LM2 Cells || cell line=MDA-MB-231 LM2 || cell type=metastatic breast cancer || chip antibody=p53 (BD-Pharmingen; 554294),"47372149,85.2,13.4,54348",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX2585782.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX2585782.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX2585782.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX2585782.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX2585782.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX2585782.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX2585782.20.bb
SRX275500,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM1133482: U2OS DMSO p53chip; Homo sapiens; ChIP-Seq,"source_name=U2OS cell line || cell type=U2OS || cell type=osteosarcoma || treatment=0.1% DMSO for 24 hr and ChIP with p53 (control for Nutlin-treated cells) || chip antibody=p53 DO-1 (Santa Cruz, sc-126)","39717260,63.2,31.6,2512",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX275500.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX275500.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX275500.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX275500.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX275500.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX275500.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX275500.20.bb
SRX275502,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM1133484: U2OS DXR p53chip; Homo sapiens; ChIP-Seq,"source_name=U2OS cell line || cell type=U2OS || cell type=osteosarcoma || treatment=0.6 ug/ml Doxorubicin for 24 hr and ChIP with p53 || chip antibody=p53 DO-1 (Santa Cruz, sc-126)","20780970,76.1,9.5,1558",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX275502.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX275502.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX275502.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX275502.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX275502.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX275502.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX275502.20.bb
SRX275504,hg19,TFs and others,TP53,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)",GSM1133486: U2OS Nutlin p53chip; Homo sapiens; ChIP-Seq,"source_name=U2OS cell line || cell type=U2OS || cell type=osteosarcoma || treatment=10 uM Nutlin-3 for 24 hr and ChIP with p53 || chip antibody=p53 DO-1 (Santa Cruz, sc-126)","35786291,33.7,63.7,8027",http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bw/SRX275504.bw,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed05/SRX275504.05.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed10/SRX275504.10.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bed20/SRX275504.20.bed,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb05/SRX275504.05.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb10/SRX275504.10.bb,http://dbarchive.biosciencedbc.jp/kyushu-u/hg19/eachData/bb20/SRX275504.20.bb
